Director at W. P. Carey (WPC) receives 2,824 restricted shares in annual equity grant

Rhea-AI Filing Summary

FLANAGAN ROBERT J reported acquisition or exercise transactions in this Form 4 filing.

W. P. Carey Inc. director Robert J. Flanagan received an equity compensation award of 2,824 shares of common stock. This award was granted at no cash cost to him as an annual grant under the company’s Amended and Restated 2017 Share Incentive Plan.

The restricted shares are scheduled to vest in full on the anniversary of the grant date, after which they will be delivered at the end of the deferral period he selected under the Deferred Compensation Plan for Non-Employee Directors. Following this award, Flanagan beneficially owns 22,756.318 shares, including 294.318 dividend equivalent rights tied to deferred shares.

Insights

Equity Compensation Analyst

Routine director equity grant with modest size and deferred delivery.

Director Robert J. Flanagan received 2,824 restricted shares of W. P. Carey Inc. common stock as an annual award under the company’s 2017 Share Incentive Plan. The grant is compensation-based, with no open-market purchase or sale involved.

The shares vest in full on the grant anniversary and are delivered at the end of a deferral period chosen under the Deferred Compensation Plan for Non-Employee Directors. This structure aligns director compensation with long-term shareholder value but does not represent a discretionary market trade.

After the grant, Flanagan holds 22,756.318 shares, including 294.318 dividend equivalent rights that mirror dividends on deferred shares. The transaction is best viewed as a standard governance and compensation event rather than a directional signal about the stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider FLANAGAN ROBERT J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,824	$0.00	--

Holdings After Transaction: Common Stock — 22,756.318 shares (Direct, null)

Footnotes (1)

1. Represents an annual award of restricted shares granted under the Issuer's Amended and Restated 2017 Share Incentive Plan, which are scheduled to vest in full on the anniversary of the grant date. The underlying shares of the Issuer's common stock will be paid at the end of the deferral period selected by the reporting person under the Issuer's Deferred Compensation Plan for Non-Employee Directors. Includes 294.318 dividend equivalent rights ("DERs") related to dividends received on deferred shares granted under the Issuer's Deferred Compensation Plan for Non-Employee Directors. These DERs become payable at the end of the deferral period selected by the reporting person. Each DER is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Restricted share grant: 2,824 shares Price per granted share: $0.0000 per share Total shares after transaction: 22,756.318 shares +2 more

5 metrics

Restricted share grant 2,824 shares Annual award of restricted shares to director

Price per granted share $0.0000 per share Equity award granted at no cash cost to director

Total shares after transaction 22,756.318 shares Director’s beneficial ownership following the grant

Dividend equivalent rights 294.318 DERs DERs tied to deferred shares under deferred compensation plan

Transaction date 2026-07-01 Date of restricted share grant

Key Terms

restricted shares, Amended and Restated 2017 Share Incentive Plan, Deferred Compensation Plan for Non-Employee Directors, dividend equivalent rights, +1 more

5 terms

restricted shares financial

"Represents an annual award of restricted shares granted under the Issuer's Amended and Restated 2017 Share Incentive Plan"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Amended and Restated 2017 Share Incentive Plan financial

"annual award of restricted shares granted under the Issuer's Amended and Restated 2017 Share Incentive Plan"

Deferred Compensation Plan for Non-Employee Directors financial

"the reporting person under the Issuer's Deferred Compensation Plan for Non-Employee Directors"

dividend equivalent rights financial

"Includes 294.318 dividend equivalent rights ("DERs") related to dividends received on deferred shares"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

DERs financial

"These DERs become payable at the end of the deferral period selected by the reporting person"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:30 PM Accepted by SEC EDGAR 07/02/2026 - 04:29 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FLANAGAN ROBERT J

(Last) (First) (Middle)

C/O W. P. CAREY INC.

ONE MANHATTAN WEST, 395 9TH AVE, 58TH FL

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
W. P. Carey Inc. [ WPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		2,824	A	$0(1)	22,756.318(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an annual award of restricted shares granted under the Issuer's Amended and Restated 2017 Share Incentive Plan, which are scheduled to vest in full on the anniversary of the grant date. The underlying shares of the Issuer's common stock will be paid at the end of the deferral period selected by the reporting person under the Issuer's Deferred Compensation Plan for Non-Employee Directors.

2. Includes 294.318 dividend equivalent rights ("DERs") related to dividends received on deferred shares granted under the Issuer's Deferred Compensation Plan for Non-Employee Directors. These DERs become payable at the end of the deferral period selected by the reporting person. Each DER is the economic equivalent of one share of the Issuer's common stock.

Remarks:

	/s/ Stephen Gardella, Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did W. P. Carey (WPC) director Robert J. Flanagan report on this Form 4?

Director Robert J. Flanagan reported receiving 2,824 restricted shares of W. P. Carey common stock. The award is an annual equity grant under the company’s share incentive plan, reflecting compensation rather than an open-market purchase or sale of shares.

How many WPC shares does Robert J. Flanagan hold after this reported transaction?

After the grant, Robert J. Flanagan beneficially owns 22,756.318 W. P. Carey shares. This total includes 2,824 newly granted restricted shares and 294.318 dividend equivalent rights that track dividends on deferred shares under the deferred compensation plan.

What type of WPC stock transaction is shown in Robert J. Flanagan’s Form 4?

The Form 4 shows an acquisition coded as “A,” representing a grant or award of 2,824 restricted shares. It is a compensation-related equity grant, not an open-market buy or sell, and carries a transaction price per share of $0.0000 in the filing.

When do Robert J. Flanagan’s newly granted WPC restricted shares vest?

The 2,824 restricted shares are scheduled to vest in full on the anniversary of the grant date. The underlying common shares will then be delivered at the end of the deferral period selected under W. P. Carey’s Deferred Compensation Plan for Non-Employee Directors.

What are the 294.318 dividend equivalent rights reported for WPC in this filing?

The 294.318 dividend equivalent rights, or DERs, relate to dividends on deferred shares under the deferred compensation plan. Each DER is economically equal to one W. P. Carey common share and becomes payable at the end of the reporting person’s chosen deferral period.

Does this WPC Form 4 indicate insider buying or selling in the market?

The Form 4 reflects a grant of 2,824 restricted shares as director compensation, not a market trade. There are no open-market purchases or sales reported, and the transaction code “A” indicates a grant, award, or other acquisition from the company.